From in vitro to ex vivo: Subcellular localization and uptake of graphene quantum dots into solid tumors

25Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Among various nanoparticles tested for pharmacological applications over the recent years, graphene quantum dots (GQDs) seem to be promising candidates for the construction of drug delivery systems due to their superior biophysical and biochemical properties. The subcellular fate of incorporated nanomaterial is decisive for transporting pharmaceuticals into target cells. Therefore a detailed characterization of the uptake of GQDs into different breast cancer models was performed. The demonstrated accumulation inside the endolysosomal system might be the reason for the particles' low toxicity, but has to be overcome for cytosolic or nuclear drug delivery. Furthermore, the penetration of GQDs into precision-cut mammary tumor slices was studied. These constitute a far closer to reality model system than monoclonal cell lines. The constant uptake into the depth of the tissue slices underlines the systems' potential for drug delivery into solid tumors.

Cite

CITATION STYLE

APA

Kersting, D., Fasbender, S., Pilch, R., Kurth, J., Franken, A., Ludescher, M., … Heinzel, T. (2019). From in vitro to ex vivo: Subcellular localization and uptake of graphene quantum dots into solid tumors. Nanotechnology, 30(39). https://doi.org/10.1088/1361-6528/ab2cb4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free